Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

Jonathon R. Campbell; David Dowdy; Kevin Schwartzman

doi:10.1371/journal.pmed.1002824

Loading metrics

Open Access

Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

Jonathon R. Campbell,

Affiliations McGill International TB Centre, McGill University, Montréal, Québec, Canada, Respiratory Epidemiology and Clinical Research Unit, Montréal Chest Institute, McGill University Health Centre, Montréal, Québec, Canada

http://orcid.org/0000-0003-2341-2166

⨯
David Dowdy,

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
⨯
Kevin Schwartzman

* E-mail: kevin.schwartzman@mcgill.ca

Affiliations McGill International TB Centre, McGill University, Montréal, Québec, Canada, Respiratory Epidemiology and Clinical Research Unit, Montréal Chest Institute, McGill University Health Centre, Montréal, Québec, Canada

http://orcid.org/0000-0002-3354-1159

⨯

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

Jonathon R. Campbell,
David Dowdy,
Kevin Schwartzman

Published: June 6, 2019
https://doi.org/10.1371/journal.pmed.1002824

About the Authors

Jonathon R. Campbell

Affiliations McGill International TB Centre, McGill University, Montréal, Québec, Canada, Respiratory Epidemiology and Clinical Research Unit, Montréal Chest Institute, McGill University Health Centre, Montréal, Québec, Canada

http://orcid.org/0000-0003-2341-2166

David Dowdy

Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

Kevin Schwartzman

* E-mail: kevin.schwartzman@mcgill.ca

http://orcid.org/0000-0002-3354-1159

Competing Interests

The authors have declared that no competing interests exist.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Public and occupational health
Is the Subject Area "Public and occupational health" applicable to this article?

Thanks for your feedback.
Canada
Is the Subject Area "Canada" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Measles
Is the Subject Area "Measles" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.